Form 4: Insmed Director Leo Lee Receives RSU Grant

Insmed Incorporated director Leo Lee was granted 3,305 restricted stock units as part of his annual compensation.

Summary

• Director Leo Lee acquired 3,305 restricted stock units (RSUs) on May 13, 2026.
• Each RSU represents a contingent right to receive one share of common stock.
• The RSUs vest in full on the first anniversary of the grant date, subject to continued board service and meeting attendance requirements.
• The total beneficial ownership of common stock for Leo Lee is now 57,971 shares, following a correction for a previous 11-share clerical overstatement.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on the company's operational outlook.

Positives

• Director alignment with shareholder interests through equity-based compensation.
• Correction of previous clerical error ensures accurate reporting of beneficial ownership.

Negatives

• Clerical error identified in previous reporting of beneficial ownership.

Risks

• Vesting of RSUs is contingent upon the director remaining on the Board of Directors and meeting a 75% attendance threshold for board meetings.

Future Outlook

The RSUs are scheduled to vest on the first anniversary of the grant date, May 13, 2027, provided the director meets the specified service and attendance criteria.

Management Comments

• The RSUs were granted for no consideration.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory disclosure regarding director compensation and does not signal a change in company strategy or financial performance.

Comparison to Industry Standards

• The use of RSUs for director compensation is a standard practice among mid-cap biotechnology companies to align board incentives with long-term shareholder value.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity grant to a director.

Next Steps

• Vesting of the 3,305 RSUs on May 13, 2027, subject to board service and attendance requirements.

Key Dates

Keywords

Insmed, INSM, Form 4, Insider Trading, Director Compensation, Restricted Stock Units